STOCK TITAN

CLOV (NASDAQ: CLOV) Form 144 shows 5,833 RSUs proposed sale; prior 10b5-1 sales listed

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC submitted a Form 144 reporting the proposed sale of 5,833 Restricted Stock Units on 03/14/2026. The filing also discloses prior 10b5-1 sales by Jamie Reynoso: 4,597 shares on 01/20/2026 and 2,102 shares on 01/07/2026, with reported dollar amounts of 11,871.75 and 5,319.32, respectively.

Positive

  • None.

Negative

  • None.

Insights

Form 144 lists a proposed sale of 5,833 RSUs and two recent 10b5-1 sales by Jamie Reynoso.

The filing records a proposed sale of 5,833 Restricted Stock Units dated 03/14/2026. It also documents two executed 10b5-1 dispositions: 4,597 shares on 01/20/2026 and 2,102 shares on 01/07/2026, with the dollar figures shown in the excerpt.

These entries are routine notice filings under resale rules; cash outcomes and further execution details are not provided in the excerpt. Subsequent public filings would show completion or proceeds if and when sales occur.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the CLOV Form 144 report?

The filing reports a proposed sale of 5,833 Restricted Stock Units dated 03/14/2026. It also lists two prior 10b5-1 sales by Jamie Reynoso: 4,597 and 2,102 shares on 01/20/2026 and 01/07/2026.

Who is listed as the seller on the CLOV Form 144?

Morgan Stanley Smith Barney LLC is named as the filer for the proposed RSU sale. The executed 10b5-1 sales are attributed to Jamie Reynoso in the excerpt, with addresses shown for reporting purposes.

How many shares were sold under the 10b5-1 plans in the excerpt?

The excerpt shows two 10b5-1 sales totaling 6,699 shares: 4,597 shares on 01/20/2026 and 2,102 shares on 01/07/2026, with accompanying dollar figures in the filing.

Do the Form 144 entries confirm cash proceeds to the issuer?

The excerpt does not state who receives proceeds. The entries list share counts and dollar figures for executed sales; the filing does not attribute proceeds to the issuer or selling holders in the provided text.

Are the reported sales described as 10b5-1 transactions?

Yes. The two executed dispositions by Jamie Reynoso in January are labeled as 10b5-1 Sales on the filing, indicating they were made under a prearranged trading plan as disclosed in the excerpt.
Clover Health Investments Corp

NASDAQ:CLOV

View CLOV Stock Overview

CLOV Rankings

CLOV Latest News

CLOV Latest SEC Filings

CLOV Stock Data

1.03B
414.89M
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
JERSEY CITY